Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
49 hedge funds and large institutions have $33.8M invested in Alimera Sciences in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less funds holding
Funds holding: 54 → 49 (-5)
35% less capital invested
Capital invested by funds: $51.9M → $33.8M (-$18.1M)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
58% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
+$3.13M |
| 2 |
Millennium Management
New York
|
+$309K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$202K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$194K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$81.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$2.22M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.2M |
| 3 |
SM
Scale Management
Foster City,
California
|
-$894K |
| 4 |
Goldman Sachs
New York
|
-$885K |
| 5 |
State Street
Boston,
Massachusetts
|
-$598K |
ALIM Hedge Fund Activity: Q2 2016 in Review
49 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2016, worth a combined $33.8M — down 35% from $51.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ALIM and 9 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 8 added.
The largest buyer was J. Goldman & Co, adding an estimated $3.13M. The largest seller was OrbiMed, cutting an estimated $2.22M.
- 49 institutional investors held Alimera Sciences (ALIM) as of Q2 2016, down from 54 in Q1 2016.
- Funds reported $33.8M of Alimera Sciences stock for Q2 2016, down 35% quarter-over-quarter.
- 9 funds opened new Alimera Sciences positions in Q2 2016 and 14 closed out, a net change of -5 holders.
- The largest Alimera Sciences buyer in Q2 2016 was J. Goldman & Co, an estimated $3.13M added.
- The largest Alimera Sciences seller in Q2 2016 was OrbiMed, an estimated $2.22M sold.
Based on aggregated 13F filings for Q2 2016.